Literature DB >> 28027111

A Validation Study of the International Consensus Diagnostic Criteria for Neuroleptic Malignant Syndrome.

Ronald J Gurrera1, Gino Mortillaro, Varadaraj Velamoor, Stanley N Caroff.   

Abstract

BACKGROUND: Neuroleptic malignant syndrome requires prompt recognition for effective management, but there are no established diagnostic criteria. This is the first validation study of recently published international expert consensus (IEC) diagnostic criteria, which include priority points assigned on the basis of the importance of each criterion for making a diagnosis of neuroleptic malignant syndrome.
METHODS: Data were extracted from 221 archived telephone contact reports of clinician-initiated calls to a national telephone consultation service from 1997 to 2009; each case was given a total priority point score on the basis of the IEC criteria. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision, (DSM-IV-TR) research criteria, in original form and modified to accept less than "severe" rigidity, served as the primary diagnostic reference standard. Consultants' diagnostic impressions were used as a secondary reference standard. Receiver operating characteristic curve analysis was used to optimize the priority point cutoff score with respect to the reference standards.
RESULTS: Area under the receiver operating characteristic curve ranged from 0.715 (95% confidence interval, 0.645-0.785; P = 1.62 × 10) for consultant diagnoses to 0.857 (95% confidence interval, 0.808-0.907; P < 5 × 10) for modified DSM-IV-TR criteria. The latter was associated with 69.6% sensitivity and 90.7% specificity.
CONCLUSIONS: Agreement was best between IEC criteria with a cutoff score of 74 and modified DSM-IV-TR criteria (sensitivity, 69.6%; specificity, 90.7%); this cutoff score demonstrated the highest agreement in all comparisons. Consultant diagnoses showed much better agreement with modified, compared with original, DSM-IV-TR criteria, suggesting that the DSM-IV-TR criterion of "severe" rigidity may be more restrictive than what most knowledgeable clinicians use in practice.

Entities:  

Mesh:

Year:  2017        PMID: 28027111     DOI: 10.1097/JCP.0000000000000640

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN: 0271-0749            Impact factor:   3.153


  10 in total

Review 1.  [Neuroleptic malignant syndrome].

Authors:  R Knorr; J Schöllkopf; E Haen
Journal:  Nervenarzt       Date:  2018-03       Impact factor: 1.214

2.  Neuroleptic malignant syndrome: a concealed diagnosis with multitreatment approach.

Authors:  Ana Velosa; António Neves; J Bernardo Barahona-Corrêa; Albino J Oliveira-Maia
Journal:  BMJ Case Rep       Date:  2019-06-17

Review 3.  Drug-induced movement disorders.

Authors:  Stephen R Duma; Victor Sc Fung
Journal:  Aust Prescr       Date:  2019-04-01

4.  Clinical Practice Guidelines for Management of Medical Emergencies Associated with Psychotropic Medications.

Authors:  Sandeep Grover; Siddharth Sarkar; Ajit Avasthi
Journal:  Indian J Psychiatry       Date:  2022-03-23       Impact factor: 2.983

5.  Neuroleptic malignant syndrome with thyroid disorder: An unusual case report.

Authors:  Fan Zhang; Parisa Kanzali; Vadim Rubin; Chris Paras; Joel Goldman
Journal:  Medicine (Baltimore)       Date:  2017-09       Impact factor: 1.889

6.  A retrospective analysis of cases with neuroleptic malignant syndrome and an evaluation of risk factors for mortality.

Authors:  Aynur Sahin; Mustafa Cicek; Ozgen Gonenc Cekic; Mucahit Gunaydin; Demet Saglam Aykut; Ozgur Tatli; Yunus Karaca; Mualla Aylin Arici
Journal:  Turk J Emerg Med       Date:  2017-11-27

7.  Risk of Neuroleptic Malignant Syndrome with Vesicular Monoamine Transporter Inhibitors.

Authors:  Stanley N Caroff
Journal:  Clin Psychopharmacol Neurosci       Date:  2020-05-31       Impact factor: 2.582

8.  Neuroleptic malignant-like syndrome associated multiple system atrophy: report on three cases.

Authors:  Yan Lin; Lin Ma; Nan Zhang; Ruihua Li; Wenjing Jiang
Journal:  BMC Neurol       Date:  2022-02-25       Impact factor: 2.474

Review 9.  Differentiating tardive dyskinesia: a video-based review of antipsychotic-induced movement disorders in clinical practice.

Authors:  Robert A Hauser; Jonathan M Meyer; Stewart A Factor; Cynthia L Comella; Caroline M Tanner; Rose Mary Xavier; Stanley N Caroff; Leslie Lundt
Journal:  CNS Spectr       Date:  2020-11-20       Impact factor: 4.604

10.  Periodic Catatonia Marked by Hypercortisolemia and Exacerbated by the Menses: A Case Report and Literature Review.

Authors:  Samantha Zwiebel; Alejandro G Villasante-Tejanos; Jose de Leon
Journal:  Case Rep Psychiatry       Date:  2018-07-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.